PubRank

M Nissilä

Author PubWeight™ 37.15‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group. Lancet 1999 4.98
2 Followup study on patients with Reiter's disease and reactive arthritis, with special reference to HLA-B27. Arthritis Rheum 1982 1.83
3 Genome scan for predisposing loci for distal interphalangeal joint osteoarthritis: evidence for a locus on 2q. Am J Hum Genet 1999 1.35
4 Testing of variants of the MTHFR and ESR1 genes in 1798 Finnish individuals fails to confirm the association with migraine with aura. Cephalalgia 2006 1.16
5 Periarticular corticosteroid treatment of the sacroiliac joint in patients with seronegative spondylarthropathy. Clin Exp Rheumatol 1999 1.15
6 Cerebral vasculitis visualized by angiography in juvenile rheumatoid arthritis simulating brain tumor. Acta Rheumatol Scand 1968 1.13
7 HLA-D antigens in rheumatoid arthritis and toxicity to gold and penicillamine. Scand J Rheumatol 1986 1.12
8 Prognosis of inflammatory joint diseases. A three-year follow-up study. Scand J Rheumatol 1983 1.11
9 Combination drug therapy retards the development of rheumatoid atlantoaxial subluxations. Arthritis Rheum 2000 1.09
10 Comparison of chemical, radiation and surgical synovectomy for knee joint synovitis. Scand J Rheumatol 1978 0.99
11 Letter: HL-A antigens in juvenile rhemumatoid arthritis. N Engl J Med 1975 0.93
12 Comparison of the effects of different anti-inflammatory drugs on synovial fluid prostanoid concentrations in patients with rheumatoid arthritis. Clin Rheumatol 1985 0.93
13 Somatic serogroups, capsular types, and species of fecal Klebsiella in patients with ankylosing spondylitis. J Clin Microbiol 1999 0.92
14 HL-A27 and arthritis. Ann Clin Res 1975 0.90
15 Multiallelic polymorphism of the cartilage collagen gene: no association with osteoarthrosis. Ann Rheum Dis 1993 0.89
16 Comparison of the analgesic effect of ten nonsteroidal anti-inflammatory drugs. Br J Rheumatol 1984 0.87
17 Serum sulfhydryl levels in rheumatoid patients treated with gold thiomalate and penicillamine. Scand J Rheumatol 1978 0.86
18 Molecular mimickry between HLA B27 and Yersinia, Salmonella, Shigella and Klebsiella within the same region of HLA alpha 1-helix. Clin Exp Immunol 1991 0.84
19 Serum soluble interleukin-2 receptor predicts early remission in patients with recent-onset rheumatoid arthritis treated with a single disease-modifying antirheumatic drug. Clin Exp Rheumatol 2005 0.83
20 Effects of non-steroidal anti-inflammatory drugs and prednisolone on synovial fluid white cells, prostaglandin E2, leukotriene B4 and cyclic AMP in patients with rheumatoid arthritis. Scand J Rheumatol 1990 0.83
21 Intraarticular osmic acid in postinfectious arthritis persisting after treated bacterial arthritis. J Rheumatol 1990 0.82
22 Letter: HL-A 27 and rheumatoid arthritis. Lancet 1974 0.82
23 Efficacy and safety of meloxicam in patients with rheumatoid arthritis. J Rheumatol 1997 0.82
24 Evaluation of Epilepsy Expert--a decision support system. Comput Methods Programs Biomed 1994 0.81
25 Renal acidification and hypergammaglobulinemia. A study of rheumatoid arthritis. Acta Med Scand 1970 0.81
26 Comparison of penicillamine and gold treatment in early rheumatoid arthritis. Scand J Rheumatol 1978 0.81
27 IgA class serum antibodies against three different Klebsiella serotypes in ankylosing spondylitis. Br J Rheumatol 1998 0.80
28 Serum copper in rheumatoid arthritis and ankylosing spondylitis. Ann Med Exp Biol Fenn 1968 0.79
29 Cell-mediated and humoral immune responses to total hip replacement under spinal or general anaesthesia. Acta Anaesthesiol Scand 1990 0.79
30 IgA1 and IgA2 subclass antibodies against Klebsiella pneumoniae in the sera of patients with peripheral and axial types of ankylosing spondylitis. Ann Rheum Dis 1995 0.79
31 Antibodies to Klebsiella pneumoniae, Escherichia coli and Proteus mirabilis in the sera of patients with axial and peripheral form of ankylosing spondylitis. Br J Rheumatol 1995 0.79
32 Pulmonary involvement in patients with rheumatoid arthritis. Scand J Respir Dis 1975 0.78
33 IgM, IgA and IgG class serum antibodies against Klebsiella pneumoniae and Escherichia coli lipopolysaccharides in patients with ankylosing spondylitis. Br J Rheumatol 1994 0.78
34 Morphological findings in joint cartilage after osmic acid treatment. Scand J Rheumatol 1977 0.78
35 Differences in the production of arachidonic acid metabolites between healthy and rheumatic synovial fibroblasts in vitro. A preliminary study. Scand J Rheumatol 1984 0.78
36 Treatment of hemiplegic migraine with triptans. Eur J Neurol 2007 0.78
37 Osmic acid treatment for rheumatoid synovitis. Ann Clin Res 1975 0.76
38 Proquazone (Biarison) and indomethacin (Indocid) in the treatment of ankylosing spondylitis. Two comparative, clinical, double-blind studies. Scand J Rheumatol Suppl 1978 0.76
39 Absence of increased frequency of degenerative joint changes after osmic acid injections. Scand J Rheumatol 1978 0.75
40 Reversible renal side effects of intra-articular osmic acid injection. Scand J Rheumatol 1978 0.75
41 Prevalence of Sindbis-related (Pogosta) virus infections in patients with arthritis. Clin Exp Rheumatol 2003 0.75
42 D-penicillamine effects on prostanoid production in adherent rheumatic synovial cells in primary culture. Prostaglandins Leukot Med 1987 0.75
43 Clinical experience with osmic acid in the treatment of joint effusion in rheumatoid arthritis. Preliminary report of a controlled clinical trial. Adv Clin Pharmacol 1974 0.75
44 [The diagnostic significance of synovial fluid examination]. Duodecim 1974 0.75
45 Osmic acid in rheumatoid synovitis. A controlled study. Scand J Rheumatol 1977 0.75
46 Indoprofen versus indomethacin and placebo. A double-blind three-way cross-over trial in rheumatoid arthritis. Eur J Rheumatol Inflamm 1981 0.75
47 Immunological effects of Biarison in the treatment of rheumatoid arthritis and systemic lupus erythematosus. A preliminary report. Scand J Rheumatol 1980 0.75
48 [Relief of pain by 9 anti-rheumatism analgesics]. Duodecim 1983 0.75
49 Plasma levels and urinary excretion of prostaglandins in patients with rheumatoid arthritis. Clin Rheumatol 1983 0.75
50 Differences in prostanoid production between healthy and rheumatic synovia in vitro. Agents Actions 1987 0.75
51 Effects of long-term aurothiomalate and D-penicillamine treatments on renal function and urinary excretion of prostanoids in patients with rheumatoid arthritis. Int J Clin Pharmacol Res 1988 0.75
52 [Osmic acid therapy in rheumatoid arthritis]. Duodecim 1972 0.75
53 Conversion of patients with rheumatoid arthritis from the conventional to a microemulsion formulation of cyclosporine: a double blind comparison to screen for differences in safety, efficacy, and pharmacokinetics. J Rheumatol 1999 0.75
54 Eicosanoid production in rheumatoid synovitis. Agents Actions 1989 0.75
55 Osmic acid in rheumatoid synovitis. A controlled study. Scand J Rheumatol 1977 0.75
56 Use of osmic acid in the topical treatment of exudative synovitis of the knee joint. Scand J Rheumatol Suppl 1979 0.75
57 Low-dose penicillamine treatment of RA. Comparison of 600 mg and 300 mg regimens. Scand J Rheumatol 1982 0.75
58 Epidemiology. Scand J Rheumatol Suppl 1975 0.75
59 Effects of antirheumatic drugs on renal function and eicosanoid excretion. Scand J Rheumatol Suppl 1987 0.75
60 Antirheumatic drugs and eicosanoid synthesis. Scand J Rheumatol Suppl 1987 0.75
61 Effect of nonsteroidal anti-inflammatory drugs on the renal excretion of uric acid. Clin Rheumatol 1983 0.75